Then, we conducted an analysis in the CCLE database and found that the FoxP3 expression was higher in RCC cell lines with BAP1 or SETD2 mutation than their wild-type cell lines (Figure 1F). The gene discussed is FOXP3; the disease is renal cell adenocarcinoma.